We would love to hear your thoughts about our site and services, please take our survey here.
very true, we seem to be in the dark, mushroom mode
The partners behind AGILE actively encourage other pharmaceutical companies and academic institutions to put forward new COVID-19 treatment candidates for consideration.
They are still desperate..;)
https://www.liverpool.ac.uk/coronavirus/research-and-analysis/faster-testing/
So we continue to wait very patiently for the route forward Sareum will take with 1801 & 2
let the MM's do as they wish, hold tight, deep breath, few months and my thoughts Sareum will be gone or lock stock and x2 Tyk2 stonking deals ;) Q4 round the corner;)
https://www.elrig.org/portfolio/drug-discovery-2021/
Perfect platform for Sareum to advertise their molecules, unless they have other plans;)
few big names already on their programme..
Potential for Sareum, low or no tox and its game on. Yep id say its game on;)
Note only US at moment, but must bode well for Sareum. Interesting read
https://www.evaluate.com/vantage/articles/news/policy-and-regulation/jaks-capped-arthritis-fda-might-not-be-finished
Expertise in virology, including practical experience in the isolation, culture and manipulation of human viruses. Ability to design, prosecute and interpret experimental studies independently. Expertise in assay development and validation. Preferred Qualifications: If you have the following characteristics, it would be a plus: Experience working with respiratory viruses, complex in vitro disease models, and in vivo models of infection. Experience of working in multidisciplinary teams and collaborating across organisational boundaries. Flexibility, with the ability to prioritize multiple projects to meet timelines while maintaining attention to detail and high-performance standards. Outstanding verbal and written communication skills with the capability to present data to multi-disciplinary audiences. Excellent record keeping and organisational skills. Prior experience of selecting and validating drug targets. Strong understanding of small- and/or large-molecule drug discovery. Previous experience in the biotechnology or pharmaceutical industry. Prior experience of supervising or mentoring junior scientists.
https://jobs.sciencecareers.org/job/562197/scientific-investigator-infectious-diseases/
Ummmm wonder what GSK have in their pipeline;)
Give us a Bill and make us a pill ;)
It also allows new treatments to be added and ineffective treatments to be dropped throughout the course of the trial. Previously, four drugs were evaluated by the trial. The results showed that remdesivir, hydroxychloroquine, lopinavir and interferon had little or no effect on hospitalized patients with covid-19.
Drop and add when they like,
https://www.livemint.com/news/india/icmr-starts-recruiting-participants-for-who-solidarity-plus-trial-11630412384121.html
https://www.msn.com/en-gb/news/world/our-baby-s-heart-suddenly-stopped-child-covid-deaths-surge-in-indonesia-as-delta-variant-spreads/ar-AANSDKE?ocid=entnewsntp
its not what we want to hear...
Times a healer T2, all the best, it wouldn't be the same board without ya ;)
Your a tough wotsit;)
https://researchprofessionalnews.com/rr-news-europe-innovation-2021-8-joint-austrian-danish-israeli-covid-fund-still-lacking-a-purpose/
Agile EPPT updated last week, still no CST1 update?? so my guessing is Sareum will definitely be trying WHO Solidarity CT
https://clinicaltrials.gov/ct2/show/NCT04746183
THE WORLD WOULD DEFINATLEY HEAR ABOUT THAT ;)
Is it just me or anyone else have a red dot feeling for tomorrow morning??
Oh my up and down like oars draws, been checking blood pressure more often
So why spend all this time writing articles like this one...
Despite research efforts on novel COVID-19 therapeutics, no specific FDA-approved treatment has been identified to manage its symptoms in humans effectively. The evidence provided in this review highlights patients with high-risk factors, especially those with elevated IL-6 levels, may particularly benefit from clinically approved neutralizing antibodies against IL-6R. This can potentially attenuate the hyper-inflammatory response leading to respiratory failure and viral spread within the host.
Additionally, current clinical trials have shifted their primary focus to finding vaccines and therapeutics marketed and/or broad-spectrum, meaning effective against various types of viruses
Really, so no specific FDA-approved treatment has been identified...
YET ;)
Just hold tight, were gonna be rolling inTyk
https://www.mdpi.com/2076-393X/9/8/938/htm
GLALTH's and firm believers. Were in AIM so AIM HIGH ;)
Apol's if already shared..
Must read ;)
https://www.mdpi.com/2072-6694/13/16/4171/htm
Modern day science, why oh why , big pharma's probably hate the fact they gotta splash out, but they will ;)
They robbed the weak, buy order filled, that's my take on their shenanigans.
they raided straight after the trading statement...opportunity knocked, so will they try again? cant see it, news could drop anytime..
Interesting Edison posted earlier, calming nerves? or more cryptic messages??...
Have a great weekend all, holding tight and feeling positive, nothing goes up in a straight line, distorted to feed appetites ;)